Review article

Rosacea

Epidemiology, Pathogenesis, Clinical Presentation, and Treatment

Dtsch Arztebl 2007; 104(24): A-1741

Lehmann, P M

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Lehmann P: Rosazea. Klinik, Pathogenese, Therapie. Hautarzt 2005; 56: 871–87.
2. Plewig G, Kligman AM: Acne and Rosacea. Berlin, Heidelberg: Springer, 3rd edition, 2000; 365.
3. Schöfer H: Rosazea: Klinik und aktuelle Therapie. Stuttgart, New York: Georg Thieme Verlag, 2003.
4. Berg M, Liden S: An epidemiological study of rosacea. Acta Derm Venereol 1989; 69: 419–23. MEDLINE
5. Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E: Rosacea: disturbed defense against brain overheating. Arch Dermatol 1989; Res 281: 66–72. MEDLINE
6. Nagasaki T, Brinnel H, Hales JR, Ogawa T: Selective brain cooling in hyperthermia: the mechanisms and medical implications. Med Hypotheses 1998; 50: 203–11. MEDLINE
7. Wilkin JK: Rosacea: pathophysiology and treatment. Arch Dermatol 1994; 130: 359–62. MEDLINE
8. Crawford GH, Pelle MT, James WD: Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327–41. MEDLINE
9. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R et al.: Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 445: 584–7. MEDLINE
10. Lehmann P, Arens A: Rosacea fulminans. In: Dermatologie an der Schwelle zum neuen Jahrtausend (Hrsg. A. Plettenberg, W.N. Meigel, I. Moll). Berlin, Heidelberg: Springer Verlag 2000; 257–9.
11. O'Leary PA, Kierland RR: Pyoderma faciale. Arch Dermatol 1940; 41: 451–62.
12. Plewig G, Jansen T, Kligman AM: Pyoderma faciale – a review and report of 20 additional acses: Is it rosaea? Arch Dermatol 1992; 128; 1611–7. MEDLINE
13. Hölzle E, Jansen T, Plewig G: Morbus Morbihan – Chronisch persistierendes Ödem des Gesichtes. Hautarzt 1995; 46: 796–8. MEDLINE
14. Wohlrab J, Lueftl M, Marsch WC: Persistent erythema and edema of the midthird and upper aspect of the face (morbus morbihan): evidence of hidden immunologic contact urticaria and impaired lymphatic drainage. J Am Acad Dermatol 2005; 52: 595–602. MEDLINE
15. Jansen T, Melnik B, Plewig G: Gramnegative Follikulitis als Begleitkomplikation bei Rosazea. Akt Dermatol 1994; 20: 381–4.
16. Leyden JJ, Thew M, Kligman AM: Steroid rosacea. Arch Dermatol 1974; 111: 619–22. MEDLINE
17. Segaert S, van Cutsem E: Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol 2005; 16: 1425–33. MEDLINE
18. Gutzmer R, Werfel T, Kapp A, Elsner J: Kutane Nebenwirkungen einer EGF-Rezeptor-Blockade und deren Management. Hautarzt 2006; 57: 509–13. MEDLINE
19. Van Zuuren EJ, Graber MA, Hollis S, Chaudrdhry M, Gupta AK, Gover M: Interventions for rosacea. Cochrane database syst Rev 2004; (1): CD00326. MEDLINE
20. Lehmann P: Klinische Studien zur topischen Therapie mit Metronidazol bei Rosazea. In: Rosazea – Klinik und aktuelle Therapie. Schöfer) H (ed.), Stuttgart: Georg Thieme Verlag 2003; 41–50.
21. Altinyazar HC, Koca R, Tekin NS, Esturk E: Adapalene vs. Metronidazole gel for the treatment of rosacea. Int J Dermatol 2005; 44: 252–5. MEDLINE
22. Czernielewski J, Liu Y: Comparison of 15 % azelaic acid gel and 0,75 % metronidazole gel for the topical treatment of papulopustular rosacea. Arch Dermatol 2004; 140: 1282–3. MEDLINE
23. Bleicher PA, Charles JH, Sober AJ: Topical metronidazole therapy for rosacea. Arch Dermatol 1987; 123: 609–14. MEDLINE
24. Dahl MV, Katz I, Krueger GG et al.: Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998; 134: 679–83. MEDLINE
25. Erdoan FG, Yurtsever P, Aksoy D, Eskioglu F: Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998; 134: 884–5. MEDLINE
e1. Guerrera M, Parodi A, Cipriani C, Divano C, Rebora A: Flushing in rosacea: a possible mechanism. Arch Dermatol Res 1982; 272: 311–6.
e2. Ljubojeviae S, Basta-Juzbasiae A, Lipozeneiae J: Steroid dermatitis resembling rosacea: aetiopathogenesis and treatment. J Eur Acad Dermatol Venereol 2002; 16: 121–6. MEDLINE
e3. Elewski BE, Fleischer AB Jr, Pariser DM: A comparison of 15 % azelaic acid gel and 0,75 % metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial. Arch Dermatol 2003; 139: 1444–500. MEDLINE
e4. Vogt E, Friedrich HC: Orale 13-cis-Retinsäure-Therapie bei Adenoma sebaceum symmetricum und schwerster Akne- und Rosazeaform. Z Hautk 1982; 58: 646–67.

Info

Specialities